search query: @indexterm Bio-technology / total: 177
references: 37-46 / 177
« previous page | next page »
 titleyearauthor
37.
Density and strength of ties in innovation networks: an analysis of multimedia and biotechnology
European management review
2005 : WINTER, VOL. 2:3, p. 179-197
 2005 Gilsing, V.
Nooteboom, B.
38.
Knowledge dynamics, firm strategy, mergers and acquisitions in the biotechnology based sectors
Economics of innovation and new technology
2005 : JAN-MAR, VOL. 14:1-2. p. 103-124
 2005 Saviotti, P.
Looze, M-A. de
Maupertus, M.A.
39.
Einflüsse der Biotechnologie auf die strategische Planung in der Pharmazeutischen Industrie
Betriebswirtschaftliche Forschung und Praxis
2004 : MAY/JUN, 3, p. 292-305
 2004 Kaufmann, L.
Schmidt, D.
40.
Non-additivity in portfolios of exploration activities: a real options-based analysis of equity alliances in biotechnology
Strategic Management Journal
2004 : NOV, VOL. 25:11, p. 1045-1061
 2004 Vassolo, R.S.
Anand, J.
Folta, T.B.
41.
Collaboration in biotechnology: how inter-firm relations strengthen research efforts in the USA
International Journal of Technology Management
2004 : VOL. 27:4, p. 452-464
 2004 Suarez-Villa, L.
42.
Transgenic organisms and the failure of a free market argument
Business Ethics
2004 : OCT, VOL. 13:4, p. 354-371
 2004 Cooley, D.R.
43.
Innovation, product development and market value: evidence from the biotechnology industry
Economics of innovation and new technology
2004 : DEC, VOL. 13:8, p. 747-760
 2004 Rzakhanov, Z.
44.
On linking business ethics, bioethics and bioterrorism
Journal of Business Ethics
2004 : MAY, VOL. 51:2, p. 211-220
 2004 Simms, M.
45.
Competitive costs of disclosure by biotech IPOs
Journal of Accounting Research
2004 : MAY, 42:2, p. 319-355
 2004 Guo, R-J.
Lev, B.
Zhou, N.
46.
The influence of firms' and industries' legitimacy on the flow of capital into high-technology ventures
Strategic organization
2004 : FEB, VOL. 2:1, p. 9-34
 2004 Deeds, D.L.
Mang, P.Y.
Frandsen, M.L.
« previous page | next page »
SCIMA